ALTERED TRANSCRIPTION OF AN ONCOGENE IN CHRONIC MYELOID LEUKAEMIA

E. Canaani; D. Steiner-Saltz; E. Aghai; R. P. Gale; A. Berrebi; E. Januszewicz

doi:10.1016/S0140-6736(84)90997-8

ALTERED TRANSCRIPTION OF AN ONCOGENE IN CHRONIC MYELOID LEUKAEMIA

E. Canaani^*
, D. Steiner-Saltz
, E. Aghai
, R. P. Gale
, A. Berrebi
, E. Januszewicz

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

112 Scopus citations

Abstract

The oncogene abl, which resides on chromosome 9, is translocated to chromosome 22 as part of the Philadelphia (Ph¹) chromosome. Leukaemic cells from 5 of 6 patients with chronic myelogenous leukaemia (CML) and the Ph¹ chromosome were found to contain a new 8 kb abl RNA transcript. This finding raises the possibility that the abl oncogene is directly involved in the development of CML. It is suggested that the abl gene's expression is altered by the DNA rearrangement in the translocation.

Original language	English
Pages (from-to)	593-595
Number of pages	3
Journal	The Lancet
Volume	323
Issue number	8377
DOIs	https://doi.org/10.1016/S0140-6736(84)90997-8
State	Published - 17 Mar 1984
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/S0140-6736(84)90997-8

Cite this

@article{c091bff3c0344638b97b448460d945d0,

title = "ALTERED TRANSCRIPTION OF AN ONCOGENE IN CHRONIC MYELOID LEUKAEMIA",

abstract = "The oncogene abl, which resides on chromosome 9, is translocated to chromosome 22 as part of the Philadelphia (Ph1) chromosome. Leukaemic cells from 5 of 6 patients with chronic myelogenous leukaemia (CML) and the Ph1 chromosome were found to contain a new 8 kb abl RNA transcript. This finding raises the possibility that the abl oncogene is directly involved in the development of CML. It is suggested that the abl gene's expression is altered by the DNA rearrangement in the translocation.",

author = "E. Canaani and D. Steiner-Saltz and E. Aghai and Gale, \{R. P.\} and A. Berrebi and E. Januszewicz",

year = "1984",

month = mar,

day = "17",

doi = "10.1016/S0140-6736(84)90997-8",

language = "אנגלית",

volume = "323",

pages = "593--595",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier B.V.",

number = "8377",

}

TY - JOUR

T1 - ALTERED TRANSCRIPTION OF AN ONCOGENE IN CHRONIC MYELOID LEUKAEMIA

AU - Canaani, E.

AU - Steiner-Saltz, D.

AU - Aghai, E.

AU - Gale, R. P.

AU - Berrebi, A.

AU - Januszewicz, E.

PY - 1984/3/17

Y1 - 1984/3/17

N2 - The oncogene abl, which resides on chromosome 9, is translocated to chromosome 22 as part of the Philadelphia (Ph1) chromosome. Leukaemic cells from 5 of 6 patients with chronic myelogenous leukaemia (CML) and the Ph1 chromosome were found to contain a new 8 kb abl RNA transcript. This finding raises the possibility that the abl oncogene is directly involved in the development of CML. It is suggested that the abl gene's expression is altered by the DNA rearrangement in the translocation.

AB - The oncogene abl, which resides on chromosome 9, is translocated to chromosome 22 as part of the Philadelphia (Ph1) chromosome. Leukaemic cells from 5 of 6 patients with chronic myelogenous leukaemia (CML) and the Ph1 chromosome were found to contain a new 8 kb abl RNA transcript. This finding raises the possibility that the abl oncogene is directly involved in the development of CML. It is suggested that the abl gene's expression is altered by the DNA rearrangement in the translocation.

UR - https://www.scopus.com/pages/publications/0021349413

U2 - 10.1016/S0140-6736(84)90997-8

DO - 10.1016/S0140-6736(84)90997-8

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 6142307

AN - SCOPUS:0021349413

SN - 0140-6736

VL - 323

SP - 593

EP - 595

JO - The Lancet

JF - The Lancet

IS - 8377

ER -

ALTERED TRANSCRIPTION OF AN ONCOGENE IN CHRONIC MYELOID LEUKAEMIA

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this